Atrial Fibrillation Trials: Will They Teach Us What We Need to Know?

American Journal of Cardiology

Volumn 82, Issue 7 A, 1998, Pages 86N-91N

  Kowey, Peter R ^a   Marinchak, Roger A ^b   Rials, Seth J ^b   Heaney, Susan ^b   Bharucha, David B ^b  

^a LANKENAU HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; DILTIAZEM; DOFETILIDE; FLECAINIDE; IBUTILIDE FUMARATE; PROPAFENONE; SOTALOL; TEDISAMIL;

CARDIOVERSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATION; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RATE; HEART RHYTHM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT CARE; PRIORITY JOURNAL; SINUS RHYTHM;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIAC PACING, ARTIFICIAL; CLINICAL TRIALS; ELECTRIC COUNTERSHOCK; HUMANS; RESEARCH DESIGN;

EID: 0031764537     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00741-3     Document Type: Article

References (33)

1. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987;317:669-674.
2. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-1573.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
4. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
5. Ganz LI, Antman EM. Antiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol 1997;8:1175-1189.
6. Capucci A, Boriani G, Botto GL, Lenzi T, Rubino I, Falcone C, Trisolino G, Della Casa S, Binetti N, Cavazza M, et al. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994;74:503-505.
7. Cox JL. The surgical treatment of atrial fibrillation, IV: surgical technique. J Thorac Cardiovasc Surg 1991;101:584-592.
8. Mackstaller LL, Alpert JS. Atrial fibrillation: a review of mechanism, etiology, and therapy. Clin Cardiol 1997;20:640-650.
9. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996;94:1585-1591.
10. The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. Atrial fibrillation follow-up investigation of rhythm management - the AFFIRM study design. Am J Cardiol 1997;79:1198-1202.
11. Hohnloser SH, Kuck KH. Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trial. PACE Pacing Clin Electrophysiol 1997;20:1989-1992.
12. Roy D, Talajic M, Thibault B, Dubuc M, Nattel S, Eisenberg M, Ciampi A, and the CTAF Investigators. Pilot study and protocol of the Canadian Trial of Atrial Fibrillatinon. Am J Cardiol 1997;80:464-468.
13. Murray KT. Ibutilide. Circulation 1998;97:493-497.
14. Suttorp MJ, Kingma JH, Jessurun ER, Lie-A-Huen L, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.
15. Tieleman RG, De Langen C, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
16. Arzbaecher R, Gemperline J, Haklin M, Buscemi P. Rapid drug infusion for termination of atrial fibrillation in an experimental model. PACE 1998;21:288-291.
17. Grimm RA, Stewart WJ, Black IW, Thomas JD, Klein AL. Should all patients undergo transesophageal echocardiography before electrical conversion of atrial fibrillation? J Am Coll Cardiol 1994;23:533-541.
18. Klein AL, Grimm RA, Black TW, Stoddard MF, Orsinelli DA, Manning WJ, Leung DY, Miller DP. Assessment of cardioversion using transesophageal echocardiography compared to conventional therapy: the ACUTE randomized pilot study. (Abstr.) Circulation 1994;90:I-121.
19. Pritchett ELC, McCarthy EA, Wilkinson WE. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 1991;114:539-544.
20. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;117:141-150.
21. Simons GR, Eisenstein EL, Shaw LJ, Mark DB, Pritchett ELC. Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular arrhythmias. Am J Cardiol 1997;80:1551-1557.
22. Lauer MS, Eagle KA. Arrhythmias following cardiac surgery. In: Podrid PJ, Kowey PR, eds. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. Baltimore: Williams & Wilkins, 1995:1206-1218.
23. Kowey PR, Dalessandro DA, Herbertson R, Briggs B, Wertan MC, Rials SJ, Filart RA, Marinchak RA. Effectiveness of digitalis with or without acebutolol in preventing atrial arrhythmias after coronary artery surgery. Am J Cardiol 1996; 79:1114-1117.
24. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmias early after coronary artery bypass grafting. Am J Cardiol 1992;69:963-965.
25. Daoud EG, Strickberger A, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD, Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-1791.
26. Gervasio A, Estes NI, Schneller S, Flaker G. Does dual chamber or atrial pacing prevent atrial fibrillation? The need for a randomized controlled trial. PACE Pacing Clin Electrophysiol 1992;15:1109-1113.
27. Prakash A, Saksena S, Hill M, Berg J, Gryzmolowicz P, Mathew P, Krol RB, Kauskik RR. Outcome of patients with drug refractory atrial fibrillation/flutter and bradyarrhythmias using long-term dual site atrial pacing. (Abstr.) PACE Pacing Clin Electrophysiol 1995;18:809.
28. Langberg JJ, Chin MC, Rosenqvist M, Cockrell J, Dullet N, Van Hare G, Griffin JC, Scheinman MM. Catheter ablation of the atrioventricular junction with radiofrequency energy. Circulation 1989;80:1527-1535.
29. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni G, Gasparini M, Raviele A, Lolli G, Paparella N, Acquarone S. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study. Circulation 1997;96:2617-2624.
30. Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994;331:910-917.
31. Haissaguerre M, Gencel L, Fischer B, Le Metayer P, Poquet F, Marcus FL, Clementy J. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994;5:1045-1052.
32. Movsowitz C, Callans DJ, Schwartzman D, Gottlieb C, Marchlinski FE. The results of atrial flutter ablation in patients with and without a history of atrial fibrillation. Am J Cardiol 1996;78:93-96.
33. Ludentz B, Pfeiffer D, Tebbenjohanns J, Jung W. Nonpharmacologic strategies for treating atrial fibrillation. Am J Cardiol 1996;77(suppl):45A-52A.